# Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT2 Infected Patients

> **NCT02482077** · PHASE4 · COMPLETED · sponsor: **Humanity and Health Research Centre** · enrollment: 112 (actual)

## Conditions studied

- Chronic Hepatitis C Infection

## Interventions

- **DRUG:** SOF+RBV
- **DRUG:** SOF+DCV
- **DRUG:** LDV/SOF

## Key facts

- **NCT ID:** NCT02482077
- **Lead sponsor:** Humanity and Health Research Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2017-12-31
- **Final completion:** 2018-03-15
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2018-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02482077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02482077, "Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT2 Infected Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02482077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*